Saturday 17 October 2026
Export NNOX’s income statement to Excel — free account
Nano-X Imaging Ltd.
NNOX Healthcare Medical Devices
Nano-X Imaging Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $13.0 million, up 15.4% from fiscal 2024. In the quarter to June 2026, revenue grew 36.7%, EPS fell 243.5%, free cash flow fell 21.4% and total debt fell 12.0%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.
0.45
0.04
−8.16%
Follow NNOX
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
3 | 4 | 3 | 3 |
+8 more TTM periods Free account |
| (98.98%) | (50.12%) | (45.62%) | (34.75%) | ||
| (84.82%) | (44.40%) | (40.31%) | (30.95%) | ||
ROIC |
(168.62%) | (57.58%) | (52.17%) | (31.48%) | |
Return on Tangible Assets |
(205.34%) | (112.22%) | (94.27%) | (65.02%) | |
Average Days of Receivables |
44.06 | 55.54 | 56.43 | 57.47 | |
Free Cash Flow per Share |
(0.74) | (0.72) | (0.69) | (0.70) | |
Free Cash Flow |
(52.09) | (49.88) | (45.00) | (45.27) | |
Capital Expenditures |
(5.39) | (5.46) | (4.21) | (4.36) | |
| Other line items | |||||
Cash ROIC |
(48.95%) | (28.81%) | (23.44%) | (22.07%) | |
Accounts Receivable Turnover |
8.30 | 7.39 | 6.82 | 7.18 | |
Accounts Payable Turnover |
30.92 | 12.38 | 10.13 | 17.76 | |
Inventory Turnover |
24.13 | 10.69 | 11.31 | 13.17 | |
Average Days of Payables |
11.41 | 32.55 | 40.81 | 21.15 | |
Days of Inventory on Hand |
18.24 | 44.52 | 43.42 | 39.97 | |
Tax Rate |
(0.01) | (0.02) | (0.02) | 0.00 | |
Research and Development Expense of Revenue |
121.08% | 131.27% | 147.73% | 160.94% | |
Selling, General and Administrative Expense of Revenue |
189.07% | 196.87% | 209.29% | 210.39% | |
Share Based Compensation of Revenue |
23.18% | 26.62% | 32.18% | 38.95% | |
Operating CF/Net income |
0.40 | 0.58 | 0.54 | 0.73 | |
Depreciation/Fixed assets |
0.36 | 0.38 | 0.40 | 0.25 | |
Capex/Depreciation |
(0.47) | (0.47) | (0.36) | (0.37) | |
Revenue per Share |
0.22 | 0.21 | 0.20 | 0.19 | |
Operating CF per Share |
(0.67) | (0.64) | (0.63) | (0.64) | |
Capex per Share |
(0.08) | (0.08) | (0.06) | (0.07) | |
Capex to Sales |
0.34 | 0.38 | 0.32 | 0.35 |
Columns are period end dates